封面
市场调查报告书
商品编码
1935356

成人及儿童血液浓缩器市场按产品类型、最终用户及地区划分

Adult and Pediatric Hemoconcentrators Market, By Product Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2026 年,成人和儿童血液浓缩器市场价值为 1,430 万美元,预计到 2033 年将达到 1,770 万美元,2026 年至 2033 年的复合年增长率为 3.3%。

报告覆盖范围 报告详情
基准年: 2025 2026年市场规模: 1430万美元
历史数据时期: 2020年至2024年 预测期: 2026年至2033年
预测期(2026-2033年)复合年增长率: 3.30% 预计2033年价值: 1770万美元

血液浓缩器是医疗设备,由医护人员或循环系统(操作体外循环机的医护人员)在手术过程中使用,用于浓缩红血球并去除血液中多余的水分。手术期间,患者的全部血液都会流经血液浓缩器。

血液浓缩器在心臟搭桥手术中备受关注,因为它们能为患者提供自身浓缩的全血,从而减少对异体血液和血液製品的需求。它们维持组织供氧所需的血球比容,并透过保存血小板和血浆凝血蛋白来降低术后出血风险。它们透过快速温和地去除血浆中多余的水分,同时保留血浆蛋白,从而维持血浆渗透压。此外,它们还能最大限度地减少利尿剂的使用,而利尿剂可能对某些患者有禁忌症。

市场动态

血液浓缩器被广泛认为是心臟绕道手术中清除体液的黄金标准。心血管疾病是最常见且危及生命的疾病之一。

例如,根据美国疾病管制与预防中心(CDC)发布的数据,心臟病是美国首要死因。美国每年约有63万人死于心臟病,约占所有死亡人数的四分之一。该机构报告称,美国每40秒就有一名患者突发心臟病。每分钟,美国至少有一人死于心臟病。

预计北美和亚太等主要地区心血管疾病的高发将推动预测期内对血液浓缩器的需求,并成为推动全球成人和儿童血液浓缩器市场成长的主要因素。

此外,市场上的主要企业正在寻求策略伙伴关係和合作,以扩大其市场份额。例如,2016年,Hemocol HPH系列血液浓缩器的製造商MEDIVATORS(Cantel Medical Corporation的子公司)从加拿大分销商Vantage Endoscopy(Diploma Canada Holdings Ltd.的子公司)收购了内视镜再处理资产,从而扩大了其在加拿大的直销业务。

本次调查的主要特点

  • 本报告对成人和儿童血液浓缩器市场进行了详细分析,并以 2017 年为基准年,给出了预测期(2018-2026 年)的市场规模和復合年增长率。
  • 该报告重点介绍了各个细分市场的潜在商机,并为该市场说明了一个有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、区域前景以及主要企业采取的竞争策略的重要见解。
  • 该研究根据以下参数对全球成人和儿童血液浓缩器市场的主要企业进行了分析:公司概况、财务业绩、产品系列、地理分布、分销策略、关键发展和策略以及未来计划。
  • 本报告的研究结果将帮助负责人和经营团队就即将推出的产品、技术升级、市场扩张和行销策略做出明智的决策。
  • 这份全球成人和儿童血液浓缩器市场报告的目标受众是该行业的各种相关人员,包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过各种策略矩阵轻鬆做出决策,这些矩阵用于分析成人和儿童血液浓缩器市场。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章 市场动态、监管与趋势分析

  • 市场动态
    • 司机
    • 抑制因素
    • 市场机会
  • 影响分析
  • 新产品发布和核准
  • 併购情景
  • PEST分析
  • 波特分析
  • 监管情景
  • 救赎方案
  • 流行病学

4. 2026-2033年全球成人及儿童血液浓缩器市场(依产品类型划分)

  • 成人血液浓缩器
  • 儿童血液浓缩器

5. 2026-2033年全球成人及儿童血液浓缩器市场(依最终用户划分)

  • 医院
  • 门诊手术中心
  • 其他的

6. 2026-2033年全球成人及儿童血液浓缩器市场(按地区划分)

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 法国
    • 西班牙
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲国家
  • 非洲
    • 中非
    • 南非
    • 北非
  • 中东
    • GCC
    • 以色列
    • 其他中东国家

第七章 竞争情势

  • 热图分析
  • 公司简介
    • Medivators Inc.
    • Terumo Corporation
    • LivaNova, PLC
    • Maquet(a Getinge Group company)
    • Medica SpA
    • Medtronic Plc.

第八章各节

  • 参考
  • 调查方法
简介目录
Product Code: CMI2483

Adult And Pediatric Hemoconcentrators Market is estimated to be valued at USD 14.3 Mn in 2026 and is expected to reach USD 17.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 14.3 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 3.30% 2033 Value Projection: USD 17.7 Mn

Hemoconcentrators are medical devices used by healthcare professionals or perfusionist (health care professional who operates heart-lung bypass equipment), to concentrate red blood cells and remove excess fluid from the bloodstream during surgery. During surgery, the entire blood volume of the patient passes through the hemoconcentrator.

Hemoconcentrators is gaining significant traction in cardio bypass surgery, as it reduces the need for homologous blood and blood products by providing patients with their own concentrated whole blood. It maintains the desired hematocrit level for oxygen transport to tissues; it decreases the risk of post-operative bleeding through the retention of platelets and plasma coagulation proteins; it maintains oncotic pressure by retaining plasma proteins while quickly and gently removing excess plasma water; and minimizes the need for diuretic use, which may be contraindicated for some patients.

Market Dynamics

Hemoconcentrators are widely used as gold standard for removal of fluid during cardio bypass surgery. Cardiovascular diseases are the most common and life threatening diseases.

For instance, according to the data published by Centers of Disease Control and Prevention (CDC), heart diseases are the leading cause of death in the U.S. Annually around 630,000 people in the U.S. die from heart diseases, which is around 1 in every 4 deaths. According to the same source in the U.S., one patient suffers from heart attack in every 40 seconds. Each minute, more than one person in the U.S. dies from heart disease.

Such high prevalence of cardiovascular diseases in key regions such as North America and Asia-Pacific is expected to be a major factor propelling demand for hemoconcentrators and drive global adult and pediatric hemoconcentrators market growth over the forecast period.

Furthermore, key players in the market are adopting strategic partnership and collaboration activities for expanding its presence in the market. For instance, in 2016, MEDIVATORS Inc. (a Cantel Medical Corporation company), a manufacturer of Hemocor HPH family hemoconcentrators expanded its direct sales operations in Canada by acquiring endoscope reprocessing business assets from its Canadian distributor, Vantage Endoscopy, Inc., a subsidiary of Diploma Canada Holdings Ltd.

Key features of the study

  • This report provides in-depth analysis of adult and pediatric hemoconcentrators market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2018 - 2026), considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by leading players
  • It profiles leading players in the global adult and pediatric hemoconcentrators market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Medivators Inc., Terumo Corporation, LivaNova, PLC, Maquet (a Getinge Group company), Medica S.p.A, and others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global adult and pediatric hemoconcentrators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the adult and pediatric hemoconcentrators market

Market Segmentation

  • By Product Type
    • Adult Hemoconcentrators
    • Pediatric Hemoconcentrators
  • By End User
    • Hospital
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Adult and Pediatric Hemoconcentrators Market Companies
    • Medivators Inc.
    • Terumo Corporation
    • LivaNova, PLC
    • Maquet (a Getinge Group company)
    • Medica S.p.A

Table of Contents

1. Research Objectives and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Novel Product Launch/Approval
  • Merger-Acquisition Scenario
  • PEST Analysis
  • PORTER's Analysis
  • Regulatory Scenario
  • Reimbursement Scenario
  • Epidemiology

4. Global Adult and Pediatric Hemoconcentrators Market, By Product Type, 2026 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026-2033
    • Segment Trends
  • Adult Hemoconcentrators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Pediatric Hemoconcentrators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Adult and Pediatric Hemoconcentrators Market, By End User, 2026 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026-2033
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Adult and Pediatric Hemoconcentrators Market, By Region, 2026 - 2033 (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2033
  • North America
    • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By Country/Region, 2026 - 2033 (USD Mn)
      • Central Africa
      • South Africa
      • North Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Medivators Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Terumo Corporation
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • LivaNova, PLC
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Maquet (a Getinge Group company)
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Medica S.p.A
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Medtronic Plc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact